๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

In vivo evaluation of controlled-release products

โœ Scribed by Stephen S. Hwang; William Bayne; Felix Theeuwes


Publisher
John Wiley and Sons
Year
1993
Tongue
English
Weight
550 KB
Volume
82
Category
Article
ISSN
0022-3549

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


In vitro and in vivo evaluation of contr
โœ Lars Borgstrรถm; Bo Ekman; Hans Larsson; Ido Leden; ร…ke Lindahl; Arne Melander; E ๐Ÿ“‚ Article ๐Ÿ“… 1984 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 529 KB

The bioavailability and pharmacokinetics of salicylic acid (SA) were studied after single and multiple doses of a new slow-release formulation, based on porous membrane diffusion of sodium salicylate (NaSA). A solution of NaSA and an enteric-coated tablet of NaSA were used for comparison. Dissolutio

Biodegradable poly(ether-ester) multiblo
โœ R. van Dijkhuizen-Radersma; J. R. Roosma; J. Sohier; F. L. A. M. A. Pรฉters; M. v ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 445 KB

## Abstract Multiblock poly(etherโ€ester)s based on poly(ethylene glycol), butylene terephthalate, and butylene succinate segments were evaluated for their __in vivo__ degradation and biocompatibility in order to establish a correlation with previously reported __in vitro__ results. Porous polymer s

THEOPHYLLINE CONTROLLED-RELEASE FORMULAT
โœ Zhiling Yu; Joseph B. Schwartz; Edwin T. Sugita ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 647 KB

Four experimental controlled-release oral solid dosage formulations were developed and the in vitro dissolution characteristics of theophylline from these formulations were studied in USP apparatus I. Pharmacokinetic evaluation of these formulations was carried out in eight beagle dogs under fasting

Relative bioavailability of four control
โœ R. Schall; F. O. Mรผller; H. K. L. Hundt; L. Duursema; G. Groenewoud; M. Van Dyk; ๐Ÿ“‚ Article ๐Ÿ“… 1994 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 482 KB ๐Ÿ‘ 1 views

## Abstract Four controlledโ€release nifedipine products were investigated in two clinical studies. In study 1, 22 healthy male volunteers took part in an open, multipleโ€dose, randomized, crossover study to determine the relative bioavailablity of two 10 mg controlledโ€release nifedipine tablet (Adal